reviewTop 1% cited

Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

Drugs · 2019 · Vol. 79(3) · pp. 271–289

George G. Zhanel✉(University of Manitoba)Alyssa Golden(University of Manitoba)Sheryl Zelenitsky(University of Manitoba)Karyn Wiebe(University of Manitoba)Courtney K. Lawrence(University of Manitoba)Heather J. Adam(University of Manitoba)Temilolu Idowu(University of Manitoba)Ronald Domalaon(University of Manitoba)Frank Schweizer(University of Manitoba)Michael A. Zhanel(University of Manitoba)Philippe Lagacé‐Wiens(Manitoba Health)Andrew Walkty(Manitoba Health)Ayman Noreddin(University of Sharjah)Joseph P. Lynch(University of California, Los Angeles)James A. Karlowsky(University of Manitoba)

View via DOI Publisher page

Antibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy Antibiotic Use and ResistanceCephalosporinSiderophoreMicrobiologyBacilliCarbapenemMultiple drug resistanceMedicineGramDrug resistancePharmacotherapy

MeSH terms

MeropenemCefiderocolAnimalsAnti-Bacterial AgentsCeftazidimeCephalosporinsClinical Trials as TopicDose-Response Relationship, DrugDrug CombinationsGram-Negative BacteriaHumansMolecular StructureCarbapenemsRandomized Controlled Trials as TopicGram-Negative Bacterial Infections

Citations

418

FWCI

15.51

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Antimicrobial Resistance in ESKAPE Pathogens